Find a Tender
complete
Official procurement procedure
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
No classification published
Location not published
Published value
£592,363,416
Submission deadline 26 Mar 2026, 13:00 GMT
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026". Published status: complete. Published value: £592,363,416. 2 published lots. Recorded submission deadline: 26 Mar 2026, 13:00 GMT. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | Closed 26 Mar 2026, 13:00 GMT |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £592,363,416 |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published10 Jul 2026, 10:46 BST | Last source update10 Jul 2026, 10:46 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-051a9d | ||
What is being bought
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731
Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
What changed
From the official release history
- Official notice release published
10 Jul 2026, 10:46 BST - tender value changed
9 Jun 2026, 10:09 BST - Status changed to complete
9 Jun 2026, 10:09 BST - Official notice release published
9 Jun 2026, 10:09 BST - Submission deadline changed to published date
9 Jun 2026, 10:09 BST - Status changed to active
23 Feb 2026, 14:41 GMT - Official notice release published
23 Feb 2026, 14:41 GMT - Submission deadline changed to 26 Mar 2026, 13:00 GMT
23 Feb 2026, 14:41 GMT - Official notice release published
18 Feb 2026, 12:08 GMT - Published value updated to £592,363,416
14 Jan 2026, 09:56 GMT - Official notice release published
14 Jan 2026, 09:56 GMT - Official notice release published
3 Jun 2025, 12:58 BST - Published value updated to £314,864,319
21 May 2025, 13:15 BST - Status changed to planned
21 May 2025, 13:15 BST - Official notice release published
21 May 2025, 13:15 BST - Buyer information updated
21 May 2025, 13:15 BST
Lots and requirements (2)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
10 Jul 2026, 10:46 BST - Submission deadline
26 Mar 2026, 13:00 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 6 Jul 2026, 00:00 BST · £18,903,212 - Contract active
Signed 22 Jun 2026, 00:00 BST · £813,863,584
Commercial outcome and competition
Awards ABBVIE LTD, ALFASIGMA UK LIMITED, AVENTIS PHARMA LIMITED t-a Sanofi, Accord UK Ltd, Amgen Ltd, BIOGEN IDEC LIMITED, BIOSIMILAR COLLABORATIONS IRELAND LIMITED, Celltrion Healthcare, DR REDDY'S LABORATORIES (UK) LIMITED, FRESENIUS KABI LIMITED, GEDEON RICHTER (UK) LIMITED, GLAXOSMITHKLINE UK LIMITED, JANSSEN-CILAG LIMITED, MILPHARM LIMITED, ORGANON PHARMA (UK) LIMITED Not published · Not published · active Amgen Ltd, BIOSIMILAR COLLABORATIONS IRELAND LIMITED, Celltrion Healthcare, FRESENIUS KABI LIMITED, GEDEON RICHTER (UK) LIMITED, JANSSEN-CILAG LIMITED, SANDOZ LIMITED, THORNTON & ROSS LIMITED Not published · Not published · active |
Contracts Lot 2 - CM/PHR/25/5731/02 - Ustekinumab NOFE & MAE £18,903,212 · signed 6 Jul 2026, 00:00 BST · active Contract period: 1 Sept 2026, 00:00 BST — 31 Aug 2027, 23:59 BST Lot 1 - CM/PHR/25/5731/01 - NHS Branded Tranche B - London & SOFE £813,863,584 · signed 22 Jun 2026, 00:00 BST · active Contract period: 1 Sept 2026, 00:00 BST — 31 Aug 2028, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published